Parallel Advisors LLC decreased its position in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 93.3% during the 2nd quarter, HoldingsChannel.com reports. Parallel Advisors LLC’s holdings in Nektar Therapeutics were worth $27,000 as of its most recent filing with the SEC. ProShare Advisors LLC grew its position in Nektar Therapeutics by 49.0% during the 4th quarter. Squarepoint Ops LLC acquired a new stake in shares of Nektar Therapeutics during the fourth quarter worth about $130,000. Receive News & Ratings for Nektar Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nektar Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.